Company Analysis Dr. Reddy's Laboratories
1. Summary
Advantages
- Price (14.58 $) is less than fair price (32.1 $)
- Dividends (2.72%) are higher than the sector average (1.35%).
- The stock's return over the last year (-7.43%) is higher than the sector average (-19%).
- Current debt level 9.49% is below 100% and has decreased over 5 years from 16.78%.
- The company's current efficiency (ROE=16.96%) is higher than the sector average (ROE=-73.93%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Dr. Reddy's Laboratories | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0.9% | -29.3% | -2.6% |
| 90 days | -0.8% | -8.1% | 4.3% |
| 1 year | -7.4% | -19% | 11.6% |
RDY vs Sector: Dr. Reddy's Laboratories has outperformed the "Healthcare" sector by 11.57% over the past year.
RDY vs Market: Dr. Reddy's Laboratories has significantly underperformed the market by -19.05% over the past year.
Stable price: RDY is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: RDY with weekly volatility of -0.1429% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (14.58 $) is lower than the fair price (32.1 $).
Price significantly below the fair price: The current price (14.58 $) is 120.2% lower than the fair price.
5.2. P/E
P/E vs Sector: The company's P/E (0.2151) is lower than that of the sector as a whole (27.75).
P/E vs Market: The company's P/E (0.2151) is lower than that of the market as a whole (56.15).
5.2.1 P/E Similar companies
5.3. P/BV
P/BV vs Sector: The company's P/BV (0.0365) is lower than that of the sector as a whole (10.31).
P/BV vs Market: The company's P/BV (0.0365) is lower than that of the market as a whole (17.65).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (0.0374) is lower than that of the sector as a whole (4.09).
P/S vs Market: The company's P/S indicator (0.0374) is lower than that of the market as a whole (27.91).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (10.06) is lower than that of the sector as a whole (18.11).
EV/Ebitda vs Market: The company's EV/Ebitda (10.06) is lower than that of the market as a whole (32.28).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 38% over the last 5 years.
Earnings Slowdown: The last year's return (1.54%) is below the 5-year average return (38%).
Profitability vs Sector: The return for the last year (1.54%) exceeds the return for the sector (0.2891%).
6.4. ROE
ROE vs Sector: The company's ROE (16.96%) is higher than that of the sector as a whole (-73.93%).
ROE vs Market: The company's ROE (16.96%) is lower than that of the market as a whole (39.03%).
6.6. ROA
ROA vs Sector: The company's ROA (11.47%) is higher than that of the sector as a whole (6.84%).
ROA vs Market: The company's ROA (11.47%) is higher than that of the market as a whole (11.36%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (20.74%) is lower than that of the sector as a whole (21.56%).
ROIC vs Market: The company's ROIC (20.74%) is higher than that of the market as a whole (10.1%).
8. Dividends
8.1. Dividend yield vs Market
High yield: The dividend yield of the company 2.72% is higher than the average for the sector '1.35%.
8.2. Stability and increase in payments
Dividend stability: The company's dividend yield 2.72% has been steadily paid over the past 7 years, DSI=0.86.
Weak dividend growth: The company's dividend yield 2.72% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
8.3. Payout percentage
Dividend Coverage: Current payments from income (11.78%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
